DOI: http://dx.doi.org/10.18203/issn.2454-2156.IntJSciRep20211955

COVID-19: unprecedented challenges for Indian pharmaceutical industry and pharma emerging markets

Abhishek Dadhich, Nirmal Gurbani

Abstract


WHO has declared the present outbreak of a new corona virus disease (COVID-19) as a global pandemic. The impact of novel COVID-19 epidemic is uncertain and unpredictable, which is also a challenging phase for the pharmaceutical industry across the globe. The rationale of this article is to compile existing research and published data and identify the various challenges among the pharmaceutical sector in India and other developing countries. To overcome from present epidemic effects such as increase in medicine price, disruption in the pharmaceutical supply chain, balancing between IPR and access to innovation and regulation on counterfeit medicine in developing countries, the certain possible strategies and solutions are discussed. The present article also emphasized the solidarity and global cooperation among developing countries to strengthen the pharmaceutical operations across India and other developing countries to meet the current demand during COVID-19 pandemic.


Keywords


COVID-19, Pandemic, Pharmaceutical supply chain, Current pharmaceutical research trend, Access to medicine, Intellectual property right

Full Text:

PDF

References


Pharmaceutical and Drug Manufactures. India- 3rd Largest Producer of Pharmaceuticals Across the World, 2020. Available at: http://www.pharma ceutical-drug. Accessed on 27 March 2021.

Invest India. Indian Pharmaceuticals-a formula for success, 2020. Available at: https://www.investindia. gov.in/sector/pharmaceuticals. Accessed on 27 March 2021.

Huifang W. China exports and imports trends, 2020. Available at: https://pharmexcil.com/ data/country_files/ImportTrends.pdf. Accessed on 27 March 2021.

RIS Policy Brief. India’s Growing Dependence on Imports in the area of Bulk Drugs, 2015. Available at: https://www.ris.org.in/sites/default/files/RIS% 20Policy%20Brief-66.pdf. Accessed on 27 March 2021.

Chatterjee P. Indian pharma threatened by COVID-19 shutdowns in China. Lancet. 2020;395(10225):675.

Market Research. The Growing Pharmaceuticals Market: Expert Forecasts and Analysis, 2018. Available at: https://blog.marketresearch.com/the-growing-pharmaceuticals-market-expert-forecasts-and-analysis. Accessed on 27 March 2021.

VOA news. Coronavirus spotlights India drug industry’s reliance on China, 2020. Available at: https://www.voanews.com/sciencehealth/coronavirusoutbreak/coronavirus-spotlights-india-drug. Accessed on 27 March 2021.

European Pharmaceutical Review. India should reduce dependence on China for APIs, says industry insider, 2020. Available at: https://www.european pharmaceuticalreview.com/news/115163/india-should-reduce- dependence-on-china-for-apis-says-industry-insider/. Accessed on 27 March 2021.

James T. India’s Growing Dependence on Imports in the area of Bulk Drugs, 2020. Available at: https://www.ris.org.in/sites/default/files/RIS%20Policy%20Brief-66.pdf. Accessed on 27 March 2021.

Grand View Research. Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication, And Segment Forecasts, 2020–2027, 2020. Available at: https://www.grandview research.com/industryanalysis/global-clinical-trials-market. Accessed on 27 March 2021.

European Pharmaceutical Review. Potential COVID-19 therapeutics currently in development, 2020. Available at: https://www.europeanpharmaceutical review.com/article/115842/potential-covid-19-therapeutics. Accessed on 27 March 2021.

ET Burea. ICRA downgrades Indian pharma on China lockdown, 2020. Available at: https://economictimes.indiatimes.com/markets/stocks/news/icra- downgrades-indian-pharma-on-china-lockdown/articleshow/74235993.cms. Accessed on 27 March 2021.

Arnum P. Indian Government Looks to Increase Domestic API Mfg, 2020. Available at: https://dcatvci.org/6411-indian-government-looks-to-increase- domestic-api-mfg. Accessed on 27 March 2021.

PIB Delhi. Cabinet approves Promotion of domestic manufacturing of critical Key Starting Materials/Drug Intermediates and Active Pharmaceutical Ingredients in the country, 2020. Available at: https://pib.gov.in/PressReleasePage. aspx. Accessed on 27 March 2021.

Ameex technologies. Impact of Covid-19 on Pharmaceutical Industry, 2020. Available at: https://www.ameexusa.com/blogs/covid-19-impact-on- pharmaceutical-industry. Accessed on 27 March 2021.

EP News Bureau. Impact of COVID-19 on pharma supply chains, 2020. Available at: https://www.expresspharma.in/covid19updates/impact-of-covid- on-pharma-supply-chains/. Accessed on 27 March 2021.